BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 7 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2022. The put-call ratio across all filers is 3.11 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $43,438,000 | -67.3% | 287,350 | -68.5% | 0.08% | -65.3% |
| Q2 2022 | $132,725,000 | -51.2% | 910,892 | -60.3% | 0.22% | -35.7% |
| Q1 2022 | $271,980,000 | +28.4% | 2,293,843 | +49.2% | 0.34% | +46.2% |
| Q4 2021 | $211,880,000 | – | 1,537,480 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |